We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow %
104.07%
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.45%
2 Technology 22.86%
3 Financials 11.48%
4 Communication Services 7.14%
5 Consumer Discretionary 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BCAX
2326
Bicara Therapeutics
BCAX
$1.2B
$253K ﹤0.01%
+12,736
New +$219K
2026 Q1
0 quarters
ALLO icon
2327
Allogene Therapeutics
ALLO
$532M
$252K ﹤0.01%
+103,247
New +$207K
2026 Q1
0 quarters
ADAM
2328
Adamas Trust
ADAM
$699M
$251K ﹤0.01%
+34,099
New +$272K
2026 Q1
0 quarters
LILAK icon
2329
Liberty Latin America Class C
LILAK
$1.63B
$249K ﹤0.01%
+31,109
New +$222K
2026 Q1
0 quarters
RWT
2330
Redwood Trust
RWT
$458M
$249K ﹤0.01%
+44,449
New +$258K
2026 Q1
0 quarters
FLY
2331
Firefly Aerospace
FLY
$3.83B
$249K ﹤0.01%
+8,739
New +$213K
2026 Q1
0 quarters
AVBP icon
2332
ArriVent BioPharma
AVBP
$1.43B
$248K ﹤0.01%
+10,763
New +$243K
2026 Q1
0 quarters
GLSI icon
2333
Greenwich LifeSciences
GLSI
$255M
$248K ﹤0.01%
+10,335
New +$270K
2026 Q1
0 quarters
ABUS icon
2334
Arbutus Biopharma
ABUS
$903M
$248K ﹤0.01%
+55,152
New +$241K
2026 Q1
0 quarters
ACEL icon
2335
Accel Entertainment
ACEL
$860M
$248K ﹤0.01%
+22,711
New +$256K
2026 Q1
0 quarters
IIIN icon
2336
Insteel Industries
IIIN
$562M
$247K ﹤0.01%
+7,335
New +$252K
2026 Q1
0 quarters
WLYB icon
2337
John Wiley & Sons Class B
WLYB
$2.48B
$246K ﹤0.01%
+6,415
New +$211K
2026 Q1
0 quarters
SWBI icon
2338
Smith & Wesson
SWBI
$646M
$245K ﹤0.01%
+17,126
New +$208K
2026 Q1
0 quarters
BORR
2339
Borr Drilling
BORR
$1.25B
$245K ﹤0.01%
+42,517
New +$218K
2026 Q1
0 quarters
LXEO icon
2340
Lexeo Therapeutics
LXEO
$297M
$244K ﹤0.01%
+42,575
New +$302K
2026 Q1
0 quarters
TRTX
2341
TPG RE Finance Trust
TRTX
$487M
$244K ﹤0.01%
+31,255
New +$269K
2026 Q1
0 quarters
ROOT icon
2342
Root
ROOT
$716M
$244K ﹤0.01%
+5,525
New +$322K
2026 Q1
0 quarters
YORW icon
2343
York Water
YORW
$486M
$244K ﹤0.01%
+8,000
New +$258K
2026 Q1
0 quarters
KODK icon
2344
Kodak
KODK
$964M
$244K ﹤0.01%
+26,907
New +$205K
2026 Q1
0 quarters
ALRS icon
2345
Alerus Financial
ALRS
$791M
$243K ﹤0.01%
+10,247
New +$248K
2026 Q1
0 quarters
AVAH icon
2346
Aveanna Healthcare
AVAH
$2.71B
$242K ﹤0.01%
+37,581
New +$291K
2026 Q1
0 quarters
OCGN icon
2347
Ocugen
OCGN
$339M
$242K ﹤0.01%
+133,705
New +$231K
2026 Q1
0 quarters
GILT icon
2348
Gilat Satellite Networks
GILT
$758M
$242K ﹤0.01%
+15,996
New +$266K
2026 Q1
0 quarters
AMSF icon
2349
AMERISAFE
AMSF
$439M
$241K ﹤0.01%
+7,238
New +$261K
2026 Q1
0 quarters
CTLP
2350
DELISTED
Cantaloupe
CTLP
$241K ﹤0.01%
+22,268
New +$235K
2026 Q1
0 quarters

Similar funds

Vanguard Global Advisers's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Technology and Financials.

  • Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
  • Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.

Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.